Selected research
Industry Growth & Trends
Global Quetiapine Industry Growth and Trends Forecast to 2032
Market perspective
The global Quetiapine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Quetiapine include XiaoGan ShenYuan ChemPharm, Teva, Sun Pharmaceutical, Sandoz, Qilu Pharmaceutical, Nanjing Sunlida Biological Technology, Mylan, Lupin and Hetero, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Quetiapine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Quetiapine market size, estimates, and forecasts are presented in terms of sales volume (kg) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Quetiapine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Quetiapine.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Quetiapine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Quetiapine Market by Company
XiaoGan ShenYuan ChemPharm
Teva
Sun Pharmaceutical
Sandoz
Qilu Pharmaceutical
Nanjing Sunlida Biological Technology
Mylan
Lupin
Hetero
Shanghai Haoyuan Chemexpress
Dr. Reddy's
Aurobindo
AstraZeneca
Wuhan Fortuna Chemical
Waterstone Technology
Toronto Research Chemicals
Nanjing Chemlin Chemical
EMMX Biotechnology
BOC Sciences
AlliChem
Quetiapine Segment by Type
Purity 97%
Purity 98%
Others
Quetiapine Segment by Application
Adult
Aged
Quetiapine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Quetiapine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Quetiapine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Quetiapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity 97%
- Purity 98%
- Others
Applications
- Adult
- Aged
Companies covered
- XiaoGan ShenYuan ChemPharm
- Teva
- Sun Pharmaceutical
- Sandoz
- Qilu Pharmaceutical
- Nanjing Sunlida Biological Technology
- Mylan
- Lupin
- Hetero
- Shanghai Haoyuan Chemexpress
- Dr. Reddy's
- Aurobindo
- AstraZeneca
- Wuhan Fortuna Chemical
- Waterstone Technology
- Toronto Research Chemicals
- Nanjing Chemlin Chemical
- EMMX Biotechnology
- BOC Sciences
- AlliChem
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Quetiapine Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Quetiapine Sales Estimates and Forecasts (2021-2032)
- 1.3 Quetiapine Market by Type
- 1.3.1 Purity 97%
- 1.3.2 Purity 98%
- 1.3.3 Others
- 1.4 Global Quetiapine Market Size by Type
- 1.4.1 Global Quetiapine Market Size Overview by Type (2021-2032)
- 1.4.2 Global Quetiapine Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Quetiapine Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Quetiapine Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Quetiapine Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Quetiapine Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Quetiapine Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Quetiapine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Quetiapine Industry Trends
- 2.2 Quetiapine Industry Drivers
- 2.3 Quetiapine Industry Opportunities and Challenges
- 2.4 Quetiapine Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Quetiapine Revenue (2021-2026)
- 3.2 Global Top Players by Quetiapine Sales (2021-2026)
- 3.3 Global Top Players by Quetiapine Price (2021-2026)
- 3.4 Global Quetiapine Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Quetiapine Major Company Production Sites & Headquarters
- 3.6 Global Quetiapine Company, Product Type & Application
- 3.7 Global Quetiapine Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Quetiapine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Quetiapine Players Market Share by Revenue in 2025
- 3.8.3 2025 Quetiapine Tier 1, Tier 2, and Tier 3
4 Quetiapine Regional Status and Outlook
- 4.1 Global Quetiapine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Quetiapine Historic Market Size by Region
- 4.2.1 Global Quetiapine Sales in Volume by Region (2021-2026)
- 4.2.2 Global Quetiapine Sales in Value by Region (2021-2026)
- 4.2.3 Global Quetiapine Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Quetiapine Forecasted Market Size by Region
- 4.3.1 Global Quetiapine Sales in Volume by Region (2027-2032)
- 4.3.2 Global Quetiapine Sales in Value by Region (2027-2032)
- 4.3.3 Global Quetiapine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Quetiapine by Application
- 5.1 Quetiapine Market by Application
- 5.1.1 Adult
- 5.1.2 Aged
- 5.2 Global Quetiapine Market Size by Application
- 5.2.1 Global Quetiapine Market Size Overview by Application (2021-2032)
- 5.2.2 Global Quetiapine Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Quetiapine Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Quetiapine Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Quetiapine Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Quetiapine Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Quetiapine Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Quetiapine Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 XiaoGan ShenYuan ChemPharm
- 6.1.1 XiaoGan ShenYuan ChemPharm Company Information
- 6.1.2 XiaoGan ShenYuan ChemPharm Business Overview
- 6.1.3 XiaoGan ShenYuan ChemPharm Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 XiaoGan ShenYuan ChemPharm Quetiapine Product Portfolio
- 6.1.5 XiaoGan ShenYuan ChemPharm Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Teva Quetiapine Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Sun Pharmaceutical
- 6.3.1 Sun Pharmaceutical Company Information
- 6.3.2 Sun Pharmaceutical Business Overview
- 6.3.3 Sun Pharmaceutical Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sun Pharmaceutical Quetiapine Product Portfolio
- 6.3.5 Sun Pharmaceutical Recent Developments
- 6.4 Sandoz
- 6.4.1 Sandoz Company Information
- 6.4.2 Sandoz Business Overview
- 6.4.3 Sandoz Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Sandoz Quetiapine Product Portfolio
- 6.4.5 Sandoz Recent Developments
- 6.5 Qilu Pharmaceutical
- 6.5.1 Qilu Pharmaceutical Company Information
- 6.5.2 Qilu Pharmaceutical Business Overview
- 6.5.3 Qilu Pharmaceutical Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Qilu Pharmaceutical Quetiapine Product Portfolio
- 6.5.5 Qilu Pharmaceutical Recent Developments
- 6.6 Nanjing Sunlida Biological Technology
- 6.6.1 Nanjing Sunlida Biological Technology Company Information
- 6.6.2 Nanjing Sunlida Biological Technology Business Overview
- 6.6.3 Nanjing Sunlida Biological Technology Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Nanjing Sunlida Biological Technology Quetiapine Product Portfolio
- 6.6.5 Nanjing Sunlida Biological Technology Recent Developments
- 6.7 Mylan
- 6.7.1 Mylan Company Information
- 6.7.2 Mylan Business Overview
- 6.7.3 Mylan Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Mylan Quetiapine Product Portfolio
- 6.7.5 Mylan Recent Developments
- 6.8 Lupin
- 6.8.1 Lupin Company Information
- 6.8.2 Lupin Business Overview
- 6.8.3 Lupin Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Lupin Quetiapine Product Portfolio
- 6.8.5 Lupin Recent Developments
- 6.9 Hetero
- 6.9.1 Hetero Company Information
- 6.9.2 Hetero Business Overview
- 6.9.3 Hetero Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Hetero Quetiapine Product Portfolio
- 6.9.5 Hetero Recent Developments
- 6.10 Shanghai Haoyuan Chemexpress
- 6.10.1 Shanghai Haoyuan Chemexpress Company Information
- 6.10.2 Shanghai Haoyuan Chemexpress Business Overview
- 6.10.3 Shanghai Haoyuan Chemexpress Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Shanghai Haoyuan Chemexpress Quetiapine Product Portfolio
- 6.10.5 Shanghai Haoyuan Chemexpress Recent Developments
- 6.11 Dr. Reddy's
- 6.11.1 Dr. Reddy's Company Information
- 6.11.2 Dr. Reddy's Business Overview
- 6.11.3 Dr. Reddy's Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Dr. Reddy's Quetiapine Product Portfolio
- 6.11.5 Dr. Reddy's Recent Developments
- 6.12 Aurobindo
- 6.12.1 Aurobindo Company Information
- 6.12.2 Aurobindo Business Overview
- 6.12.3 Aurobindo Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Aurobindo Quetiapine Product Portfolio
- 6.12.5 Aurobindo Recent Developments
- 6.13 AstraZeneca
- 6.13.1 AstraZeneca Company Information
- 6.13.2 AstraZeneca Business Overview
- 6.13.3 AstraZeneca Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 AstraZeneca Quetiapine Product Portfolio
- 6.13.5 AstraZeneca Recent Developments
- 6.14 Wuhan Fortuna Chemical
- 6.14.1 Wuhan Fortuna Chemical Company Information
- 6.14.2 Wuhan Fortuna Chemical Business Overview
- 6.14.3 Wuhan Fortuna Chemical Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Wuhan Fortuna Chemical Quetiapine Product Portfolio
- 6.14.5 Wuhan Fortuna Chemical Recent Developments
- 6.15 Waterstone Technology
- 6.15.1 Waterstone Technology Company Information
- 6.15.2 Waterstone Technology Business Overview
- 6.15.3 Waterstone Technology Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Waterstone Technology Quetiapine Product Portfolio
- 6.15.5 Waterstone Technology Recent Developments
- 6.16 Toronto Research Chemicals
- 6.16.1 Toronto Research Chemicals Company Information
- 6.16.2 Toronto Research Chemicals Business Overview
- 6.16.3 Toronto Research Chemicals Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.16.4 Toronto Research Chemicals Quetiapine Product Portfolio
- 6.16.5 Toronto Research Chemicals Recent Developments
- 6.17 Nanjing Chemlin Chemical
- 6.17.1 Nanjing Chemlin Chemical Company Information
- 6.17.2 Nanjing Chemlin Chemical Business Overview
- 6.17.3 Nanjing Chemlin Chemical Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.17.4 Nanjing Chemlin Chemical Quetiapine Product Portfolio
- 6.17.5 Nanjing Chemlin Chemical Recent Developments
- 6.18 EMMX Biotechnology
- 6.18.1 EMMX Biotechnology Company Information
- 6.18.2 EMMX Biotechnology Business Overview
- 6.18.3 EMMX Biotechnology Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.18.4 EMMX Biotechnology Quetiapine Product Portfolio
- 6.18.5 EMMX Biotechnology Recent Developments
- 6.19 BOC Sciences
- 6.19.1 BOC Sciences Company Information
- 6.19.2 BOC Sciences Business Overview
- 6.19.3 BOC Sciences Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.19.4 BOC Sciences Quetiapine Product Portfolio
- 6.19.5 BOC Sciences Recent Developments
- 6.20 AlliChem
- 6.20.1 AlliChem Company Information
- 6.20.2 AlliChem Business Overview
- 6.20.3 AlliChem Quetiapine Sales, Revenue and Gross Margin (2021-2026)
- 6.20.4 AlliChem Quetiapine Product Portfolio
- 6.20.5 AlliChem Recent Developments
7 North America by Country
- 7.1 North America Quetiapine Sales by Country
- 7.1.1 North America Quetiapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Quetiapine Sales by Country (2021-2026)
- 7.1.3 North America Quetiapine Sales Forecast by Country (2027-2032)
- 7.2 North America Quetiapine Market Size by Country
- 7.2.1 North America Quetiapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Quetiapine Market Size by Country (2021-2026)
- 7.2.3 North America Quetiapine Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Quetiapine Sales by Country
- 8.1.1 Europe Quetiapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Quetiapine Sales by Country (2021-2026)
- 8.1.3 Europe Quetiapine Sales Forecast by Country (2027-2032)
- 8.2 Europe Quetiapine Market Size by Country
- 8.2.1 Europe Quetiapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Quetiapine Market Size by Country (2021-2026)
- 8.2.3 Europe Quetiapine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Quetiapine Sales by Country
- 9.1.1 Asia-Pacific Quetiapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Quetiapine Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Quetiapine Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Quetiapine Market Size by Country
- 9.2.1 Asia-Pacific Quetiapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Quetiapine Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Quetiapine Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Quetiapine Sales by Country
- 10.1.1 South America Quetiapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Quetiapine Sales by Country (2021-2026)
- 10.1.3 South America Quetiapine Sales Forecast by Country (2027-2032)
- 10.2 South America Quetiapine Market Size by Country
- 10.2.1 South America Quetiapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Quetiapine Market Size by Country (2021-2026)
- 10.2.3 South America Quetiapine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Quetiapine Sales by Country
- 11.1.1 Middle East and Africa Quetiapine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Quetiapine Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Quetiapine Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Quetiapine Market Size by Country
- 11.2.1 Middle East and Africa Quetiapine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Quetiapine Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Quetiapine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Quetiapine Value Chain Analysis
- 12.1.1 Quetiapine Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Quetiapine Production Mode & Process
- 12.2 Quetiapine Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Quetiapine Distributors
- 12.2.3 Quetiapine Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst